Table 3:
DTI parameter and electrophysiologic group dataa
| FAb,c | ADC (×10−6 mm2s−1)b,c | λ‖(×10−6 mm2s−1) | λ⊥(×10−6 mm2s−1)b,c | Whole-Field VEP Amplitude (μV)b,c | Whole-Field VEP Latency (ms)b,c | |
|---|---|---|---|---|---|---|
| Patients' affected nerves (n = 26) | 0.283 ± 0.073 | 1429 ± 198 | 1786 ± 159 | 1245 ± 172 | 4.53 ± 1.17 | 132.7 ± 17.48 |
| Patients' unaffected nerves (n = 26) | 0.569 ± 0.046 | 1028 ± 146 | 1720 ± 199 | 746 ± 78 | 9.67 ± 2.52 | 94.86 ± 9.07 |
| Control nerves (n = 15) | 0.587 ± 0.023 | 1008 ± 111 | 1702 ± 199 | 729 ± 130 | 9.40 ± 3.03 | 97.77 ± 4.62 |
a
The values are mean ± SD.
b
Significant difference between nerves of controls and affected nerves of patients.
c
Significant difference between unaffected contralateral nerves and affected nerves in patients. There is no significant difference between unaffected ONs of patients and ONs of controls in all DTI measures.